however, human data remain inconclusive
Key Takeaways GLP-1 agonists are intended and approved to help with blood sugar regulation in type 2 diabetes patients, and in certain cases for clinical obesity, when no other methods have worked
So when they looked at age, baseline weight, type two diabetes, behavioral support, dietician support, that didn't have an impact, so accounting for all of that, the people in hormone replacement therapy still had better intended outcomes, which the intention was to lose weight
These medications should be avoided during pregnancy and breastfeeding, and women of reproductive potential should discontinue treatment at least 2 months before a planned pregnancy
doi: 10.22271/foodsci.2025.v6.i2a.248 76 ZanjaniSYEskandariMRKamaliKMohseniM